REMINTED THERAPEUTICS PRIVATE LIMITED
REMINTED THERAPEUTICS PRIVATE LIMITED is a UTTAR PRADESH based PRIVATE LIMITED company, Registered at dated 02-JUN-2023 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of REMINTED THERAPEUTICS PRIVATE LIMITED is U86100UP2023PTC183367 and registration number is 183367.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC KANPUR India. Authorized share capital of REMINTED THERAPEUTICS PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 10000. It aspire to serve in HOSPITAL ACTIVITIES activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
REMINTED THERAPEUTICS PRIVATE LIMITED has 2 directors PRABHAT SHARMA, ANURAG MITTAL,
The registered Email address of REMINTED THERAPEUTICS PRIVATE LIMITED is prabhatlnct2008@gmail.com and its registered address is 75 GROUND FLOOR, NASRATPURA, G T ROAD GHAZIABAD GHAZIABAD GHAZIABAD UP 201001 IN UTTAR PRADESH UTTAR PRADESH india 201001.
The current status of REMINTED THERAPEUTICS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
REMINTED THERAPEUTICS PRIVATE LIMITED
ROC KANPUR
ACTIVE
HOSPITAL ACTIVITIES
U86100UP2023PTC183367
02-JUN-2023
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
10000
CONTACT DETAILS
201001
INDIA
75 GROUND FLOOR, NASRATPURA, G T ROAD GHAZIABAD GHAZIABAD GHAZIABAD UP 201001 IN
prabhatlnct2008@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
08810998 | PRABHAT SHARMA | Director | 02/06/2023 |
10189016 | ANURAG MITTAL | Director | 02/06/2023 |
Details Updated by Companies
Quick Links
- All Registered company of UTTAR PRADESH
- Company Registered in UTTAR PRADESH
- All Registered company of GHAZIABAD in UTTAR PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.